Born in Cambridge: Meet 10 University spinouts
07 Dec 202210 University spinouts that are having an impact in the UK and around the world.
News from Cambridge Enterprise.
New approach to ‘cosmic magnet’ manufacturing could reduce reliance on rare earths in low-carbon technologies
25 Oct 2022Researchers have discovered a potential new method for making the high-performance magnets used in wind turbines and electric cars without the need for rare earth elements, which are almost exclusively sourced in China.
Algorithm learns to correct 3D printing errors for different parts, materials and systems
16 Aug 2022Engineers have created intelligent 3D printers that can quickly detect and correct errors, even in previously unseen designs, or unfamiliar materials like ketchup and mayonnaise, by learning from the experiences of other machines.
Powering a green revolution
23 May 2022Dr Giorgia Longobardi, founder and CEO of University spinout Cambridge GaN Devices, is harnessing the extraordinary properties of superconductor gallium nitride to halve the amount of energy we use to power our increasingly digital lives.
Low-cost device being developed to help cancer patients manage their care
05 May 2022Med-tech start-up 52 North Health has raised £1 million in its first round of funding to help it develop the NeutroCheck, a fully-integrated clinical, AI and medical device-based system for people living with cancer.
Cambridge spin-out aiming to make it easier to find and apply regulations
14 Apr 2022RegGenome, a commercial spin-out from the University of Cambridge, has announced the completion of a $6 million seed funding round.
New Head at Cambridge Enterprise Seed Funds
07 Apr 2022Cambridge Enterprise, the commercialisation arm of the University of Cambridge, has announced the appointment of Dr Christine Martin as Head of Seed Funds.
Cambridge spin-out using data analytics to extend the life of our built environment
15 Mar 2022BKwai, a construction data company that helps engineers develop smarter, more sustainable infrastructure, has raised £2.2 million in seed funding from investors led by Octopus Ventures with participation from Cambridge Enterprise and Deeptech Labs.
Cambridge vaccine expert in $42million partnership to develop 'future-proofed' coronavirus vaccines
08 Mar 2022Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million) to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that cause SARS and MERS.
Drug-screening spin-out secures new funding
23 Feb 2022A University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies make better medicines, faster. It announced today that it has closed a £2.14 million seed funding round.
